These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy. Fang LC; Merrick GS; Butler WM; Galbreath RW; Murray BC; Reed JL; Adamovich E; Wallner KE Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):992-6. PubMed ID: 20932674 [TBL] [Abstract][Full Text] [Related]
6. Prostate brachytherapy in men > or =75 years of age. Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Adamovich E Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):415-20. PubMed ID: 18374514 [TBL] [Abstract][Full Text] [Related]
7. Obesity is not predictive of overall survival following permanent prostate brachytherapy. Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Adamovich E Am J Clin Oncol; 2007 Dec; 30(6):588-96. PubMed ID: 18091052 [TBL] [Abstract][Full Text] [Related]
8. Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer. Merrick GS; Galbreath RW; Butler WM; Waller KE; Allen ZA; Lief J; Adamovich E Cancer; 2007 Jul; 110(2):289-96. PubMed ID: 17549691 [TBL] [Abstract][Full Text] [Related]
9. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591 [TBL] [Abstract][Full Text] [Related]
10. Percent positive biopsy cores as a prognostic factor for prostate cancer treated with external beam radiation. Spalding AC; Daignault S; Sandler HM; Shah RB; Pan CC; Ray ME Urology; 2007 May; 69(5):936-40. PubMed ID: 17482938 [TBL] [Abstract][Full Text] [Related]
11. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Adamovich E Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1056-62. PubMed ID: 15001245 [TBL] [Abstract][Full Text] [Related]
12. Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer. Merrick GS; Wallner KE; Butler WM; Galbreath RW; Allen ZA; Adamovich E; True L BJU Int; 2006 Aug; 98(2):324-8. PubMed ID: 16879672 [TBL] [Abstract][Full Text] [Related]
13. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen Z; Lief JH; Adamovich E Urology; 2005 Jan; 65(1):95-100. PubMed ID: 15667872 [TBL] [Abstract][Full Text] [Related]
14. Percentage of positive biopsy cores: a better risk stratification model for prostate cancer? Huang J; Vicini FA; Williams SG; Ye H; McGrath S; Ghilezan M; Krauss D; Martinez AA; Kestin LL Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1141-8. PubMed ID: 22099043 [TBL] [Abstract][Full Text] [Related]
15. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695 [TBL] [Abstract][Full Text] [Related]
16. Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy. Taira AV; Merrick GS; Galbreath RW; Wallner KE; Butler WM Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):349-54. PubMed ID: 19467793 [TBL] [Abstract][Full Text] [Related]
17. Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapy. Taira AV; Merrick GS; Galbreath RW; Butler WM; Lief JH; Wallner KE BJU Int; 2010 Sep; 106(6):809-14. PubMed ID: 20201830 [TBL] [Abstract][Full Text] [Related]
18. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores. Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846 [TBL] [Abstract][Full Text] [Related]
19. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Wong WW; Schild SE; Vora SA; Halyard MY Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]